Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid hydroperoxyl radicals (LOO•) are highly reactive chemical intermediates generated during the propagation phase of lipid peroxidation, a process that primarily affects polyunsaturated fatty acids within cellular membranes [Dixon et al., 2012, Cell]. These radicals are formed when carbon-centered lipid radicals react rapidly with molecular oxygen; they subsequently abstract hydrogen atoms from adjacent lipids, driving a self-amplifying cascade of oxidative damage that is the execution mechanism of ferroptosis [Conrad et al., 2018, Nature Chemical Biology]. The accumulation of these species leads to catastrophic membrane disruption, loss of organelle integrity, and the generation of secondary toxic electrophiles like 4-hydroxynonenal, which contribute to the pathology of neurodegenerative diseases, myocardial infarction, and acute kidney injury [Stockwell et al., 2017, Cell]. Therapeutic strategies targeting these radicals utilize radical-trapping antioxidants (RTAs), such as Ferrostatin-1 and Vitamin E, which intercept the peroxyl species to halt the peroxidation chain reaction [Zilka et al., 2017, ACS Central Science]. By neutralizing lipid hydroperoxyl radicals, these pharmacological agents prevent iron-dependent regulated cell death and protect tissues from oxidative degradation in various inflammatory and degenerative clinical contexts.
Radical-trapping antioxidants (RTAs) neutralize lipid hydroperoxyl radicals by donating a hydrogen atom (Hydrogen Atom Transfer), which converts the reactive radical into a stable lipid hydroperoxide, thereby terminating the self-propagating chain reaction of lipid peroxidation [Zilka et al., 2017, ACS Central Science].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid hydroperoxyl radical (LOO•) (LOO•).